Kyverna Therapeutics’ miv-cel showed improved mobility and a favorable safety profile at one year in patients with stiff person syndrome, further derisking an upcoming FDA application, William Blair said on Thursday. The biotech plans to file for priority review this year.
Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data Read More »
Analysts were keen to see a new modality compete with Roche’s approved drug Lucentis in the late-stage trial but new safety issues could complicate the future for Merck’s candidate.
Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge Read More »
InnoCare Pharma is the latest addition to Eli Lilly’s dealmaking spree, which includes some of the biggest acquisitions this year: up to $7 billion for Kelonia Therapeutics in April and up to $7.8 billion for Centessa Pharmaceuticals in March.
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare Read More »
The new partnership follows Roche’s recent R&D expansion in Boston focused on development for cardiovascular, renal and metabolic diseases.
Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs Read More »
Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.
Backed by NVIDIA and Anthropic, Basecamp bags $140M to advance AI-designed drugs Read More »
In this episode of Denatured presented by Curium, Jennifer Smith-Parker speaks to Mike Patterson, CEO North America and Professor Sabine Brookman-May, vice president and head of Global Clinical Development. We look at the momentum behind radioligand therapy and how its diagnostic and therapeutic capabilities are improving care for more than 14 million patients worldwide.
How radioligand therapy is rewriting cancer care Read More »
Mucho antes de que James Watson y Francis Crick dibujaran la famosa estructura en doble hélice de la molécula de ADN a mediados del siglo XX, la ciencia ignoraba de qué estaba hecho exactamente el núcleo de nuestras células. Se sabía que existía una s …
Albrecht Kossel: El sabio que descifró las bases químicas de la vida y el ADN Read More »
Durante buena parte del siglo XX, el registro de una boca se hacía de una sola manera: una cubeta cargada con una pasta de alginato o silicona, unos minutos de espera incómoda y un molde de escayola que se guardaba en una estantería. Ese molde era, literalmente, el archivo del p …
Pedirle a una computadora que sea impredecible, la verdad, es algo contradictorio porque una máquina hace exactamente lo que una persona indica, paso a paso y siempre de la misma forma. Sin embargo, millones de programas necesitan cada día producir números que …
En las profundidades del cosmos existen objetos que desafían todo lo que sabemos sobre la materia convencional. Cuando una estrella masiva agota su combustible nuclear y colapsa bajo su propia gravedad, el resultado suele ser una estrella de neutrones: un remanente denso donde los protones y …
Estrellas de quarks: ¿Existen objetos creados totalmente por materia extraña? Read More »
